Incentives to Decrease Opioid Use - Pilot

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

May 1, 2021

Study Completion Date

May 15, 2021

Conditions
Substance-Related DisordersOpioid-Related DisordersBehavior Therapy
Interventions
BEHAVIORAL

App + Inputs Contingency Management

The app has programmed contingencies whereby incentives can be earned for behaviors that are inputs to abstaining from drug use (e.g., attending psychotherapy or taking SUD psychopharmacology).

BEHAVIORAL

App + Outcomes Contingency Management

The app has programmed contingencies whereby incentives can be earned for outcomes of abstaining from drug use (e.g., drug-negative saliva samples on saliva opioid tests).

Trial Locations (3)

53213

Aurora Psychiatric Hospital, Wauwatosa

60637

University of Chicago, Chicago

94720

University of California - Santa Cruz, Berkeley

All Listed Sponsors
collaborator

University of Chicago

OTHER

collaborator

University of California, Berkeley

OTHER

lead

Wake Forest University Health Sciences

OTHER

NCT04235582 - Incentives to Decrease Opioid Use - Pilot | Biotech Hunter | Biotech Hunter